OXFD Insider Trading Activity and SEC Form 4 Filings
OXFD insider trading summary
No open-market insider purchases or sales of Oxford Immunotec Global PLC (OXFD) have been reported on SEC Form 4 in the past 12 months.
Latest OXFD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2020 | Patrick J Balthrop | Director | Buy | $50K (4,000 @ $12.48) |
| May 12, 2020 | Peter Wrighton-Smith | Chief Executive Officer | Buy | $179K (15,525 @ $11.56) |
| May 11, 2020 | Peter Wrighton-Smith | Chief Executive Officer | Buy | $298K (26,000 @ $11.45) |
| May 8, 2020 | Peter Wrighton-Smith | Chief Executive Officer | Buy | $22K (2,075 @ $10.75) |
| Nov 1, 2019 | Richard A Sandberg | Director | Sell | $47K (3,000 @ $15.60) |
| Oct 1, 2019 | Peter Wrighton-Smith | Chief Executive Officer | Sell | $486K (30,000 @ $16.21) |
| Sep 24, 2019 | Peter Wrighton-Smith | Chief Executive Officer | Sell | $1.4M (80,000 @ $17.01) |
| Sep 23, 2019 | Peter Wrighton-Smith | Chief Executive Officer | Sell | $298K (20,000 @ $14.92) |
| Aug 16, 2019 | Peter Wrighton-Smith | Chief Executive Officer | Sell | $139K (10,000 @ $13.86) |
| Aug 1, 2019 | Richard A Sandberg | Director | Sell | $60K (3,000 @ $19.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.